Uniform Bio
Laboratory & Pharmaceutical Robotics · Drug Discovery
Overview
MOSgen is the first benchtop platform built for high-throughput 3D biology. Now accepting Early Access Program applications with HTS cores, pharma R&D, and translational research programs.
Funding and backers
Total raised
$1.7M
1 round on record
Latest round
$1.7M
Convertible Note · Apr 2026 · 6 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Apr 2026 | $1.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Uniform Bio Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Eric StrumingerExecutive Officer, DirectorSEC Form D
Daniel NelsonExecutive Officer, DirectorSEC Form D
David GrahamExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
AI-powered trade compliance platform for HTS classification, CROSS ruling research, and landed cost analysis. Faster, more defensible…
Search current HTS data and calculate import duties with applicable Chapter 99 and trade-remedy layers. AI classification, landed cost, and…
Biology meets artificial and human intelligence for next-generation therapeutics. Onava is built differently. Our platform compounds in…
NEXI Biotech builds translational in vitro neural models that turn preclinical research into clinical insight — so the next generation of…
We provide an award-winning 3D high-throughput screening platform for neurological diseases and drug development to researchers and…
Nosis Bio delivers breakthrough receptor-targeted RNA medicines through cutting-edge physics-aware deep learning, single cell biology, and…
Financials
Total raised
$1.7M
Latest round
Convertible Note
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Convertible Note | 2026 | $1.7M | Details |
People
Eric Struminger
Executive Officer, Director
Daniel Nelson
Executive Officer, Director
David Graham
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Raleigh
United States
HQ
Durham
United States
Regional office
400 Park Offices Drive, Suite 108, Durham, NC, 27713, US